Gene · 1645
Papers1,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nodosin Exerts an Anti-Colorectal Cancer Effect by Inhibiting Proliferation and Triggering Complex Cell Death in Vitro and in Vivo. | Front Pharmacol | 2022 | 35935881 | PubTator, text mining | PubMed |
| Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties. | Adv Pharm Bull | 2022 | 35935043 | PubTator, text mining | PubMed |
| Multimodal Dimension Reduction and Subtype Classification of Head and Neck Squamous Cell Tumors. | Front Oncol | 2022 | 35912202 | PubTator, text mining | PubMed |
| The molecular biology and therapeutic potential of Nrf2 in leukemia. | Cancer Cell Int | 2022 | 35906617 | PubTator, text mining | PubMed |
| The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression. | Front Oncol | 2022 | 35903688 | PubTator, text mining | PubMed |
| Gold Nanoparticles Contact with Cancer Cell: A Brief Update. | Int J Mol Sci | 2022 | 35887030 | PubTator, text mining | PubMed |
| Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients. | Cells | 2022 | 35883650 | PubTator, text mining | PubMed |
| Systematic whole-genome sequencing reveals an unexpected diversity among actinomycetoma pathogens and provides insights into their antibacterial susceptibilities. | PLoS Negl Trop Dis | 2022 | 35877680 | PubTator, text mining | PubMed |
| Ferroptosis: A Novel Therapeutic Direction of Spinal Cord Injury. | Comput Math Methods Med | 2022 | 35866036 | PubTator, text mining | PubMed |
| Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer. | Front Mol Biosci | 2022 | 35847989 | PubTator, text mining | PubMed |
| A Game of Infection - Song of Respiratory Viruses and Interferons. | Front Cell Infect Microbiol | 2022 | 35846766 | PubTator, text mining | PubMed |
| Regulation of Metabolism by Mitochondrial MUL1 E3 Ubiquitin Ligase. | Front Cell Dev Biol | 2022 | 35846359 | PubTator, text mining | PubMed |
| Identification of the ferroptosis-related ceRNA network related to prognosis and tumor immunity for gastric cancer. | Aging (Albany NY) | 2022 | 35835721 | PubTator, text mining | PubMed |
| Understanding Protein Protocadherin-19 (PCDH19) Syndrome: A Literature Review of the Pathophysiology. | Cureus | 2022 | 35822151 | PubTator, text mining | PubMed |
| PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance. | Life Sci Alliance | 2022 | 35820706 | PubTator, text mining | PubMed |
| A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma. | J Immunol Res | 2022 | 35812244 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer. | Cancers (Basel) | 2022 | 35804965 | PubTator, text mining | PubMed |
| Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. | J Hematol Oncol | 2022 | 35794625 | PubTator, text mining | PubMed |
| Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods. | Comput Math Methods Med | 2022 | 35774297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1645/papers?page=20